Patient pathways for rare diseases in Europe: ataxia as an example

Area of Science:

• Neurology
• Patient Care Pathways
• Rare Diseases

Background:

• Progressive ataxias are complex neurological disorders posing diagnostic and management challenges.
• Understanding patient journeys in specialist ataxia centres (SAC) versus non-specialist settings is crucial.
• Focus on early intervention and coordinated treatment across different countries.

Purpose of the Study:

• Compare patient pathways in SAC versus non-specialist settings.
• Investigate diagnosis, healthcare access, treatments, and care satisfaction.
• Analyze early intervention and treatment coordination for ataxia patients.

Main Methods:

• Conducted a patient survey in the UK, Germany, and Italy.
• Gathered data on diagnosis and management in specialist and non-specialist settings.
• Assessed utilization of primary/secondary healthcare services and patient satisfaction.

Main Results:

• Patients reported positive experiences with SAC for understanding their condition and management.
• SACs were valued for tailored care, coordinated referrals, and research opportunities.
• Identified similar barriers in accessing SACs across the UK, Germany, and Italy.

Conclusions:

• Patient satisfaction with care was generally higher in SAC compared to non-SAC.
• Study provides key insights into ataxia patient care pathways in Europe.
• Outcomes can inform policy for improving rare neurological disease treatment and care.